Evidence map›Paper›PMID 39312107›Full record

ReviewAdvances in therapy2024

Key Challenges to Understanding the Burden of Respiratory Syncytial Virus in Older Adults in Southeast Asia, the Middle East, and North Africa: An Expert Perspective.

Hakan Günen, Ashraf Alzaabi, Abdelaziz Bakhatar, Sana Al Mutairi, Kittipong Maneechotesuwan, Daniel Tan, Mohammed Zeitouni, Bhumika Aggarwal, Arnas Berzanskis, Otávio Cintra

Abstract readReview
In one paragraph

Review in Advances in therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hakan GünenSüreyyapaşa Research and Training Center for Chest Diseases and Thoracic Surgery, Health Sciences University, Istanbul, Turkey.ORCID 0000-0001-6631-4457
Ashraf AlzaabiInternal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Abu Dhabi, United Arab Emirates.
Abdelaziz BakhatarFaculty of Medicine and Pharmacy of Casablanca, Casablanca, Morocco.
Sana Al MutairiCollege of Medicine, Kuwait University, Kuwait City, Kuwait.
Kittipong ManeechotesuwanDivision of Respiratory Disease and Tuberculosis, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.ORCID 0000-0001-5940-7436
Daniel TanUniversity of the East College of Medicine, Quezon City, Philippines.
Mohammed ZeitouniPulmonary Section, Department of Medicine, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
Bhumika AggarwalGSK, Singapore, Singapore.ORCID 0000-0002-8370-9319
Arnas BerzanskisGSK, London, UK.ORCID 0009-0005-5456-405X
Otávio CintraGSK, São Paulo, Brazil. otavio.a.cintra@gsk.com.ORCID 0000-0002-3485-8780

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionRespiratory syncytial virus (RSV) is a common, highly contagious pathogen and a leading cause of serious illness among infants and older adults. While existing scientific evidence has predominantly focused on the epidemiology and disease burden of RSV in infants, data in older adults remain limited in some countries, including those in Southeast Asia (SEA) and the Middle East and North Africa (MENA) region. Here, we outline the key challenges for understanding the burden of RSV in older adults in SEA and the MENA region and we propose opportunities for improving understanding and eventually reducing the impact of RSV. MAIN FINDINGS AND

conclusionsA key challenge identified by the expert group, particularly in older adults, is a lack of awareness (among healthcare professionals, policy makers, and the public) of RSV burden and the associated risks for severe outcomes. This is often confounded by the complexities of underdiagnosis, surveillance limitations, and comorbidities. To address these issues, we suggest medical education initiatives for physicians in SEA and the MENA region to better understand the need to protect older adults from RSV, and encourage more widespread routine testing to better understand the burden of RSV. We also recommend surveillance studies in these regions to provide comprehensive and accurate epidemiological data on RSV in older adults. Finally, in the absence of current surveillance data in these regions, we propose extrapolating existing global data and local pediatric data to inform the likely burden of RSV in older adults. A graphical abstract is available with this article.

Indexed as

Respiratory Syncytial Virus InfectionsAfrica, NorthernAgedAsia, SoutheasternCost of IllnessHumansMiddle EastAfrica, NorthernAsia, SoutheasternConsensusMiddle EastRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus Vaccines

Identifiers

PMID39312107
PMCPMC11480108

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.